New South Wales commits $4.3m to festival drug checking

New South Wales has committed AUD $4.3 million to continue drug checking at selected music festivals from October 2026. The decision follows a 12-month trial across 12 events, where more than 1,800 people used the service and around 1,500 samples were tested. NSW Health will now work with organisers and harm-reduction groups to select up to 15 festivals each year.

The trial reached people who had not used harm-reduction services before

The service was free, anonymous and voluntary. Festivalgoers could hand over a small sample of a pill, powder, crystal or liquid to forensic chemists, who analysed its main components and, where possible, potency. Peer workers then explained the result and talked through the risks. The process did not certify a substance as safe; it gave people more information before they decided what to do next.

That contact point turned out to be one of the strongest findings. The government says a majority of users had not previously engaged with health or harm-reduction services. In other words, the testing tent was not just a chemistry station. It created a short window where people who might never book an appointment or call a service were willing to talk honestly about what they were planning to take.

The evaluation found fewer urgent presentations at participating festivals

An independent evaluation led by the University of Sydney found the trial was associated with a reduction in urgent drug-related hospital presentations and ICU admissions compared with previous editions of the same festivals. The evaluation also found that people changed their plans more often when the result did not match what they expected. That is an important distinction: the value of testing is not simply identifying a substance, but changing behaviour when the information is bad news.

Parliamentary figures released earlier this year give more detail on what was found. Across the 12 events, 1,846 people accessed the service and 1,480 samples were tested. Around 66% of users said they expected MDMA, 19% ketamine and 8% cocaine. In 86% of tests the sample contained only what the person expected; about 5% contained the expected drug plus another substance, while fewer than 3% contained only an unexpected substance.

Up to 15 festivals a year will be selected

NSW Health says the permanent programme will prioritise festivals where testing is expected to have the greatest harm-reduction impact. Size, event type, location and the likelihood of drug-related harm will all be considered. The 2025–26 trial included Field Day, Laneway, Lost Paradise, Knockout Outdoor, EPIK, HTID, Mighty Hoopla and several other events across the state.

The exact 2026–27 list has not yet been published. Services will continue to be delivered by NSW Health with NUAA and festival organisers, using forensic chemists from NSW Health Pathology. Amnesty bins will remain inside the testing area for anyone who decides to dispose of a substance after receiving the result.

This is a pretty significant policy shift for Australian festival culture

For years, pill testing in Australia has been argued over as if acknowledging drug use at festivals somehow encouraged it. The NSW model has moved the conversation towards something more practical: people are already taking substances, so what happens when you give them chemical information and a non-judgemental conversation before they do? The trial produced enough measurable benefit for the state to fund the service beyond a pilot.

There are still limits. Testing cannot identify every component at every concentration, and police may still be present elsewhere at festivals. NSW Health also makes clear that illicit drug use remains illegal and that no test removes the risk. The programme sits alongside medical tents, water, chill-out areas, overdose education and naloxone rather than replacing any of them.

The first permanent-service festivals will be announced after consultation with organisers. That list is the next thing to watch. The policy is already locked in; the real test now is how consistently the service can be delivered across events with very different audiences, sites and risk profiles.